Renal Function in Patients with or without a Left Ventricular Assist Device Implant During Listing for a Heart Transplant
Open Access
- 10 November 2020
- journal article
- research article
- Published by International Scientific Information, Inc. in Annals of Transplantation
- Vol. 25, e925653-e925653-8
Abstract
BACKGROUND:Left ventricular assist device (LVAD) implantation may improve kidney function, but in patients awaiting heart transplantation, the long-term effects of LVAD implantation on renal function and subsequent clinical outcome are unclear. MATERIAL AND METHODS:We analyzed data in patients with LVAD implants (n=139) and without LVAD implants (n=1038) who were listed for a heart transplant at our institution between 2000 and 2019. The primary endpoint was an impairment in renal function (decrease of creatinine-based estimated glomerular filtration rate [eGFR] by ≥30%) up to a maximum of 2 years after listing. Secondary endpoints were chronic kidney disease stage 4 or 5, heart transplantation, survival during listing, and 1-year survival after transplantation. RESULTS:Values for eGFR increased after LVAD implantation (P=0.001) and were higher at the time of waitlisting in the LVAD group than in the non-LVAD group (P=0.002), but were similar between groups at the end of waitlisting (P=0.75). Two-year freedom from renal impairment was 50.6% and 66.7% in the LVAD and non-LVAD groups, respectively, with a multivariable-adjusted hazard ratio for the LVAD versus the non-LVAD group of 1.78 (95% confidence interval 1.19-2.68; P=0.005). Two-year freedom from chronic kidney disease stages 4-5 was similar between study groups (LVAD group: 83.5%; non-LVAD group: 80.1%; =0.50). The 2-year probability of transplantation was slightly lower in the LVAD group than in the non-LVAD group (50.0% and 55.8%, respectively, P=0.017). However, 2-year survival on the waiting list and 1-year survival after transplantation did not differ significantly between study groups (P-values >0.20). CONCLUSIONS:Our data indicate a transient improvement in creatinine-based eGFR values by LVAD implantation without influencing survival.Keywords
This publication has 35 references indexed in Scilit:
- Epidemiology of Heart FailureCirculation Research, 2013
- Impact of long term left ventricular assist device therapy on donor allocation in cardiac transplantationThe Journal of Heart and Lung Transplantation, 2013
- Characteristics of “Stage D” heart failure: Insights from the Acute Decompensated Heart Failure National Registry Longitudinal Module (ADHERE LM)American Heart Journal, 2008
- Listing Criteria for Heart Transplantation: International Society for Heart and Lung Transplantation Guidelines for the Care of Cardiac Transplant Candidates—2006The Journal of Heart and Lung Transplantation, 2006
- Taking Heart — Cardiac Transplantation Past, Present, and FutureNew England Journal of Medicine, 2006
- Renal Function as a Predictor of Outcome in a Broad Spectrum of Patients With Heart FailureCirculation, 2006
- Chronic Kidney Disease and the Risks of Death, Cardiovascular Events, and HospitalizationNew England Journal of Medicine, 2004
- A Comparison of Prediction Equations for Estimating Glomerular Filtration Rate in Adults without Kidney DiseaseJournal of the American Society of Nephrology, 2003
- Long-Term Use of a Left Ventricular Assist Device for End-Stage Heart FailureNew England Journal of Medicine, 2001
- Selection criteria for placement of left ventricular assist devicesAmerican Heart Journal, 1995